Thus demonstrating the importance of FGFR4 as a pharmacological treatment for the inhibition of cancer in both in vitro and in vivo studies and as an inhibitor of tumor proliferation and invasion [17,39,40,41,42,43,44,45,46,47,48,49,50]. The gene discussed is FGFR4; the disease is cancer.